QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causi... Read more
Mineralys Therapeutics
3 followers
Ultima Genomics
6 followers
Obsidian Therapeutics
1 follower
Arc Institute
4 followers
Thermo Fisher Scientific
287 followers
Genentech
227 followers
Gilead Sciences
216 followers
Regeneron
184 followers
Biogen
167 followers
Vertex Pharmaceuticals
113 followers
Agilent Technologies
102 followers
Illumina
93 followers